TY - JOUR
T1 - The Sequential Organ Failure Assessment (SOFA) Score
T2 - has the time come for an update?
AU - Moreno, Rui
AU - Rhodes, Andrew
AU - Piquilloud, Lise
AU - Hernandez, Glenn
AU - Takala, Jukka
AU - Gershengorn, Hayley B
AU - Tavares, Miguel
AU - Coopersmith, Craig M
AU - Myatra, Sheila N
AU - Singer, Mervyn
AU - Rezende, Ederlon
AU - Prescott, Hallie C
AU - Soares, Márcio
AU - Timsit, Jean-François
AU - de Lange, Dylan W
AU - Jung, Christian
AU - De Waele, Jan J
AU - Martin, Greg S
AU - Summers, Charlotte
AU - Azoulay, Elie
AU - Fujii, Tomoko
AU - McLean, Anthony S
AU - Vincent, Jean-Louis
N1 - Funding Information:
RM has no competing interest to declare relevant to this article. AR has no competing interest to declare relevant to this article. LP has no competing interest to declare relevant to this article. GH has no competing interest to declare relevant to this article. JT has no competing interest to declare relevant to this article. HBG received funding from Gilead Sciences, Inc. to serve on COVID therapeutics advisory board (not related to this work). MT has no competing interest to declare relevant to this article. CMC is an Associate Editor of Critical Care—he has no other competing interest to declare relevant to this article. SNM has no competing interest to declare relevant to this article. Mervyn S has no competing interest to declare relevant to this article. ER has no competing interest to declare relevant to this article. HCP served on the surviving sepsis campaign guidelines and is physician-lead for a Michigan statewide sepsis consortium. This manuscript does not represent the views of the Department of Veterans Affairs or the US government. This material is the result of work supported with resources and use of facilities at the Ann Arbor VA Medical Center. Marcio S is founder and equity shareholder of Epimed Solutions®, which commercializes the Epimed Monitor System, a cloud-based software for ICU management and benchmarking. JFT has no competing interest to declare relevant to this article. DWdL has no competing interest to declare relevant to this article. CJ has no competing interest to declare relevant to this article. JJDW has no competing interest to declare relevant to this article. GSM has no competing interest to declare relevant to this article. CS has no competing interest to declare relevant to this article. EA has no competing interest to declare relevant to this article. AR has no competing interest to declare relevant to this article. TF has no competing interest to declare relevant to this article. ASM has no competing interest to declare relevant to this article. JLV is Editor-in-Chief of Critical Care—he has no other competing interest to declare relevant to this article. ®
Funding Information:
JJDW is supported by a Senior Clinical Investigator Grant from the Research Foundation Flanders (FWO, Ref. 1881020N).
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/1/13
Y1 - 2023/1/13
N2 - The Sequential Organ Failure Assessment (SOFA) score was developed more than 25 years ago to provide a simple method of assessing and monitoring organ dysfunction in critically ill patients. Changes in clinical practice over the last few decades, with new interventions and a greater focus on non-invasive monitoring systems, mean it is time to update the SOFA score. As a first step in this process, we propose some possible new variables that could be included in a SOFA 2.0. By so doing, we hope to stimulate debate and discussion to move toward a new, properly validated score that will be fit for modern practice.
AB - The Sequential Organ Failure Assessment (SOFA) score was developed more than 25 years ago to provide a simple method of assessing and monitoring organ dysfunction in critically ill patients. Changes in clinical practice over the last few decades, with new interventions and a greater focus on non-invasive monitoring systems, mean it is time to update the SOFA score. As a first step in this process, we propose some possible new variables that could be included in a SOFA 2.0. By so doing, we hope to stimulate debate and discussion to move toward a new, properly validated score that will be fit for modern practice.
UR - https://www.scopus.com/pages/publications/85146304358
U2 - 10.1186/s13054-022-04290-9
DO - 10.1186/s13054-022-04290-9
M3 - Article
C2 - 36639780
SN - 1466-609X
VL - 27
JO - Critical care (London, England)
JF - Critical care (London, England)
IS - 1
M1 - 15
ER -